Each year, more than 13,000 children are diagnosed with type 1 Diabetes. Diabetes is one of the most common chronic diseases in children and adolescents; ALTuCELL’s mission is to find a cure for insulin-dependent diabetes. The company, and its collaborative relationships with leaders in the field, developed because of a personal commitment of the founder Gary Harlem: the promise made to seek a cure for his son diagnosed with Type 1 Diabetes. Along the way the Harlem family has attracted interest, support and encouragement from other families and leading scientists alike who are affected by Diabetes.
ALTuCELL believes that the true path to eradication of this horrible disease which affects millions of children every year, is to alter the immune system, which itself has turned on, that has caused damage to specific cell types of pancreatic islets cluster of cells that produce insulin and other metabolic hormones. After extensive research, traveling across the globe and having meetings and communications throughout the world, Harlem has found the most practical, proficient and logical approach to deliver results and remedying this debilitating disease. ALTuCELL, Inc hopes to eliminate the need for insulin injections through this advanced therapy. Since insulin injections alone may attenuate, but not eliminate the risk for developing major complications of type 1 diabetes, at level of kidneys, cardiovascular system, nervous system and eyes. there is the unmet need for a cure.